The whitepaper discusses the importance of a third-party risk management (TPRM) program in mitigating security risks posed by third-party collaborations. It offers insights from cyber security experts on effectively implementing a TPRM, gaining stakeholder approval, and optimally using existing resources and tools.
Wall Street’s Leaders and Laggards of 2024
2024 was a mixed year for biopharma stocks, with the iShares Biotechnology ETF and SPDR S&P Biotech ETF experiencing small decreases. Federal Reserve decisions caused
